Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr;40(4):967-73.
doi: 10.1007/s00268-015-3316-x.

Transduodenal Ampullectomy for the Treatment of Early-Stage Ampulla of Vater Cancer

Affiliations

Transduodenal Ampullectomy for the Treatment of Early-Stage Ampulla of Vater Cancer

Huisong Lee et al. World J Surg. 2016 Apr.

Abstract

Background: Transduodenal ampullectomy (TDA) is a less invasive procedure than pancreaticoduodenectomy (PD). However, the outcomes of TDA and PD have been compared rarely in early ampullary cancer.

Methods: From September 1994 to June 2013, the patients who underwent curative surgery for Tis or T1 ampulla of Vater neoplasm were identified. The patients were divided into two groups according to the types of surgery; TDA group and PD group. The patient characteristics and survival outcomes were retrospectively investigated between the two groups.

Results: Total 137 patients were included in this study. The 18 patients underwent TDA and 119 patients underwent PD for Tis or T1 ampullary cancer. There was no lymph node metastasis in the patients with Tis tumor although 10 of 104 patients had lymph node metastasis in T1 cancer. After a median follow-up of 50 months (range, 6-148), there were no recurrence after TDA for Tis tumor. However, the TDA was associated with higher local recurrence rate than PD in the patients with T1 ampullary cancer on Kaplan-Meier survival analysis (p = 0.007).

Conclusion: The TDA is feasible treatment for Tis ampulla of Vater neoplasm. However, TDA is unsuitable for the treatment of T1 ampulla of Vater cancer.

PubMed Disclaimer

References

    1. Ann Surg Oncol. 2008 Nov;15(11):3178-86 - PubMed
    1. Hepatogastroenterology. 2007 Jan-Feb;54(73):10-4 - PubMed
    1. Ann Surg. 2013 Feb;257(2):315-22 - PubMed
    1. HPB (Oxford). 2013 Nov;15(11):829-38 - PubMed
    1. Hepatogastroenterology. 2014 Jan-Feb;61(129):12-7 - PubMed

Publication types

LinkOut - more resources